Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1Naloxone
(D08249)		1件: Naloxone1件: Naloxone (D08249) 💬3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬2件: 6, 226 💬
2NALOXONE HYDROCHLORIDE
(D08249)		1件: Naloxone1件: Naloxone (D08249) 💬3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 226 💬
3NALOXONE HYDROCHLORIDE DIHYDRATE
(D08249)		1件: Naloxone1件: Naloxone (D08249) 💬3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
4Oxycodone naloxone prolonged release tablets
(D08249)		2件: Naloxone,
Oxycodone		2件: Oxycodone ,
Naloxone (D08249) 💬		3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 226 💬
5Oxycodone/naloxone prolonged release t
(D08249)		3件: Manganese citrate,
Naloxone,
Oxycodone		2件: Oxycodone ,
Naloxone (D08249) 💬		3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 226 💬
6Oxycodone/Naloxone Prolonged Release tablets
(D08249)		2件: Naloxone,
Oxycodone		2件: Oxycodone ,
Naloxone (D08249) 💬		3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
7Oxycodone/naloxone prolonged release tablets 10 mg /5 mg
(D08249)		3件: Manganese citrate,
Naloxone,
Oxycodone		2件: Oxycodone ,
Naloxone (D08249) 💬		3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
8Oxycodone/naloxone prolonged release tablets 10/5 mg
(D08249)		3件: Manganese citrate,
Naloxone,
Oxycodone		2件: Oxycodone ,
Naloxone (D08249) 💬		3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 226 💬
9Oxycodone/naloxone prolonged release tablets 20 mg /10 mg
(D08249)		3件: Manganese citrate,
Naloxone,
Oxycodone		2件: Oxycodone ,
Naloxone (D08249) 💬		3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
10Oxycodone/naloxone prolonged release tablets 20/10 mg
(D08249)		3件: Manganese citrate,
Naloxone,
Oxycodone		2件: Oxycodone ,
Naloxone (D08249) 💬		3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 226 💬
11Oxycodone/naloxone prolonged release tablets 5 mg /2.5 mg
(D08249)		3件: Manganese citrate,
Naloxone,
Oxycodone		2件: Oxycodone ,
Naloxone (D08249) 💬		3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
12Oxycodone/naloxone prolonged release tablets 5/2.5 mg
(D08249)		3件: Manganese citrate,
Naloxone,
Oxycodone		2件: Oxycodone ,
Naloxone (D08249) 💬		3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 226 💬